Description

Engerix-B for Children 0.5 ml. 10 mcg. №10 Vial

Ingredients

Engerix-B for Children contains Hepatitis B surface antigen (HBsAg) adsorbed on aluminum hydroxide.

Dosage

Children: The recommended dose is 0.5 ml (10 mcg) administered intramuscularly in a two-dose schedule.

Indications

Engerix-B for Children is indicated for active immunization against Hepatitis B virus infection in children.

Contraindications

Do not administer Engerix-B to individuals with a history of severe allergic reaction to any component of the vaccine.

Directions

Administer the vaccine intramuscularly in the deltoid region. Shake the vial before withdrawing each dose.

Scientific Evidence

Engerix-B has been extensively studied in clinical trials and has demonstrated high efficacy in providing protection against Hepatitis B infection in children. Research published in the Journal of Pediatrics showed that the vaccine induced a robust immune response in pediatric populations, highlighting its effectiveness in preventing Hepatitis B transmission.

Additional Information

It is essential to adhere to the recommended vaccination schedule to ensure optimal protection against Hepatitis B. Engerix-B for Children has been proven to be safe and well-tolerated, with common side effects being mild and transient. Consult a healthcare professional for personalized vaccination advice.

Pharmacological Effects: Engerix-B works by stimulating the immune system to produce antibodies against the Hepatitis B virus. These antibodies provide immunity, protecting the body from future infections.

Clinical Trials: Clinical trials have shown that Engerix-B for Children is highly effective in preventing Hepatitis B infection. A study published in the Journal of Infectious Diseases demonstrated a high seroprotection rate in children following vaccination with Engerix-B.